Alfred Altomari is Director of Baudax Bio, Inc.. Currently has a direct ownership of 117,785 shares of BXRX, which is worth approximately $1,177. The most recent transaction as insider was on Apr 07, 2021, when has been sold 56,452 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K
0% 3M change
0% 12M change
Total Value Held $1,177

ALFRED ALTOMARI Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 07 2021
BUY
Grant, award, or other acquisition
-
56,452 Added 32.4%
117,785 Common Stock
Nov 23 2020
BUY
Open market or private purchase
$5,300 $1.06 p/Share
5,000 Added 7.54%
61,333 Common Stock

Also insider at

INSM
INSMED Inc Healthcare
AGRX
AGILE THERAPEUTICS INC Healthcare
AA

Alfred Altomari

Director
Princeton, NJ

Track Institutional and Insider Activities on BXRX

Follow Baudax Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BXRX shares.

Notify only if

Insider Trading

Get notified when an Baudax Bio, Inc. insider buys or sells BXRX shares.

Notify only if

News

Receive news related to Baudax Bio, Inc.

Track Activities on BXRX